You are now leaving lundbeck.com. Please note that the information contained in the site you are linking to may not be fully compliant with regulatory environment and that product related information should be checked against the corresponding consumer medicine information or by asking your doctor. Any information provided should be discussed with your health care professional and does not replace the advice and treatment of your doctor. We hope you will visit us again soon.

Go to



Můžete nás kontaktovat:

Emailem:  czech_republic@lundbeck.com / Telefonicky: +420 225 275 600

Kontaktujte naši compliance hotline

Hlášení nežádoucích příhod

Have Questions?

Get in Touch

Více z Lundbecku

Investor Relations 

Detailed information related to Lundbeck’s financial performance. Contact Palle Olesen, VP, Investor Relations:
+ 45 3083 2426 

About Us 

A global pharmaceutical company specialized in brain diseases.


For general press enquiries, please call + 45 3643 4000